A multidisciplinary multicentric approach to the identification of predictive biomarkers of response to erenumab – the protocol of the phase 4, European, open-label controlled trial of the BIOMIGA project

Daniele Martinelli, Edoardo Caronna, Hauke Basedau, Rosaria Greco, Maria Magdalena Pocora, Max Schönthaler, Roberto De Icco, Gloria Vaghi, Grazia Sances, Natascia Ghiotto, Elena Guaschino, Marta Allena, Chiara Demartini, Miriam Francavilla, Anna Pichiecchio, Rut Mas-de-les-Valls, Deborah Pareto, Àlex Rovira, Victor J. Gallardo, Laila Asskour, Eulalia Gine-Cipres, Alicia Alpuente, Marta Torres-Ferrús, Elena Ballante, Gloria Castellazzi, Jan Mehnert, Arne May, Patricia Pozo-Rosich, Cristina Tassorelli

Open source

DOI: 10.3389/fneur.2026.1878729
Published: 2026-08-31
Container: Frontiers in Neurology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1878729,
  title = {A multidisciplinary multicentric approach to the identification of predictive biomarkers of response to erenumab – the protocol of the phase 4, European, open-label controlled trial of the BIOMIGA project},
  author = {Daniele Martinelli and Edoardo Caronna and Hauke Basedau and Rosaria Greco and Maria Magdalena Pocora and Max Schönthaler and Roberto De Icco and Gloria Vaghi and Grazia Sances and Natascia Ghiotto and Elena Guaschino and Marta Allena and Chiara Demartini and Miriam Francavilla and Anna Pichiecchio and Rut Mas-de-les-Valls and Deborah Pareto and Àlex Rovira and Victor J. Gallardo and Laila Asskour and Eulalia Gine-Cipres and Alicia Alpuente and Marta Torres-Ferrús and Elena Ballante and Gloria Castellazzi and Jan Mehnert and Arne May and Patricia Pozo-Rosich and Cristina Tassorelli},
  year = {2026},
  journal = {Frontiers in Neurology},
  doi = {10.3389/fneur.2026.1878729},
  url = {https://doi.org/10.3389/fneur.2026.1878729}
}

RIS

TY  - JOUR
TI  - A multidisciplinary multicentric approach to the identification of predictive biomarkers of response to erenumab – the protocol of the phase 4, European, open-label controlled trial of the BIOMIGA project
AU  - Daniele Martinelli
AU  - Edoardo Caronna
AU  - Hauke Basedau
AU  - Rosaria Greco
AU  - Maria Magdalena Pocora
AU  - Max Schönthaler
AU  - Roberto De Icco
AU  - Gloria Vaghi
AU  - Grazia Sances
AU  - Natascia Ghiotto
AU  - Elena Guaschino
AU  - Marta Allena
AU  - Chiara Demartini
AU  - Miriam Francavilla
AU  - Anna Pichiecchio
AU  - Rut Mas-de-les-Valls
AU  - Deborah Pareto
AU  - Àlex Rovira
AU  - Victor J. Gallardo
AU  - Laila Asskour
AU  - Eulalia Gine-Cipres
AU  - Alicia Alpuente
AU  - Marta Torres-Ferrús
AU  - Elena Ballante
AU  - Gloria Castellazzi
AU  - Jan Mehnert
AU  - Arne May
AU  - Patricia Pozo-Rosich
AU  - Cristina Tassorelli
PY  - 2026
JO  - Frontiers in Neurology
DO  - 10.3389/fneur.2026.1878729
UR  - https://doi.org/10.3389/fneur.2026.1878729
ER  -

APA

Martinelli, D., Caronna, E., Basedau, H., Greco, R., Pocora, M. M., Schönthaler, M., Icco, R. D., Vaghi, G., Sances, G., Ghiotto, N., Guaschino, E., Allena, M., Demartini, C., Francavilla, M., Pichiecchio, A., Mas-de-les-Valls, R., Pareto, D., Rovira, À., Gallardo, V. J., Asskour, L., Gine-Cipres, E., Alpuente, A., Torres-Ferrús, M., Ballante, E., Castellazzi, G., Mehnert, J., May, A., Pozo-Rosich, P., & Tassorelli, C. (2026). A multidisciplinary multicentric approach to the identification of predictive biomarkers of response to erenumab – the protocol of the phase 4, European, open-label controlled trial of the BIOMIGA project. Frontiers in Neurology. https://doi.org/10.3389/fneur.2026.1878729

Source records

crossref · retrieved 2026-09-25T16:48:05.879Z